Endoscopic sinus surgery outcomes in patients with chronic rhinosinusitis and immunoglobulin deficiencies

Table 1 Characteristics of cases and controls undergoing endoscopic sinus surgery

	Patients with immunoglobulin deficiency (n = 13)	Patients without immunoglobulin deficiency (n = 26)	SMD^a
Male (n, %)	5 (39)	10 (39)	< 0.001
Age (mean ± SD)	44.2 (15)	43.7 (14)	0.040
Asthma (n, %)	6 (46)	12 (46)	< 0.001
CRSwNP (n, %)	8 (62)	16 (62)	< 0.001
CRSsNP (n, %)	5 (39)	10 (39)	< 0.001
Preoperative LMS (mean ± SD)	13.8 (± 3.0)	12.9 (± 3.2)	0.274
Follow up time in months (mean ± SD)	44 (± 36.7)	24.0 (± 22.5)	NA
Complete ESS^b	9 (69)	24 (92)	NA
Limited ESS^c	4 (31)	2 (8)	NA
Concurrent Septoplasty	2 (15)	7 (27)	NA

CRS chronic rhinosinusitis, CRSsNP chronic rhinosinusitis withoutt nasal polyps, CRSwNP chronic rhinosinusitis with nasal polyps, LMS Lund MacKay score, SD standard deviation, SMD standardized mean difference, ESS endoscopic sinus surgery
^aA SMD < 0.1 indicated a good balance between the two groups
^bComplete ESS was defined as maxillary antrostomies, total ethmoidectomies, sphenoidotomies, frontal sinusotomies, and nasal polypectomies if polyps are present
^cLimited ESS was defined as any ESS that did not fit the definition of complete ESS

ISSN: 1916-0216